Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
4.030
+0.210 (5.50%)
Sep 18, 2025, 3:30 PM EDT - Market open
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $109.12 million as of September 18, 2025. Its market cap has decreased by -68.40% in one year.
Market Cap
109.12M
Enterprise Value
-18.84M
1-Year Change
-68.40%
Ranking
Category
Stock Price
$4.03
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $109.12M, a decrease of -79.36%. That is a compound annual growth rate of -62.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 103.43M | -9.34% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.54B |
| Johnson & Johnson | 429.62B |
| AbbVie | 388.02B |
| UnitedHealth Group | 308.55B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 232.82B |